Florida's first ever leading cannabis company is taking strides towards expanding its footprint. Trulieve, which also operates from locations spread across California, Connecticut and Massachusetts, has...
This past July, retail sales of recreational cannabis in Canada climbed 15.2 percent from the month prior. Based on the sales surge, 231.6 million Canadian dollars (USD$175.6 million) in transactions were...
Almost four years since recreational cannabis in Maine was successfully voted on by residents, the first six business licenses have been issued among lucky applicants. Thanks to the state office's decision,...
Hong Kong is celebrating the launch of its very first CBD cafe — Found Cafe. The news comes as a shock to many, considering the fact that the special administrative region of the People's Republic of...
A recently published report from New Frontier Data – a pioneer in analytics, business intelligence and data for the worldwide cannabis industry – has pinned the value of a federally legal cannabis...
A new study focused on Ohio's medical cannabis program indicates that patients are unsatisfied with the cost of plant-based medicines across the state. Carried out by a group of researchers at the Ohio...
Just one month ago, the island nation of Malta encountered a shortage of high-THC medical cannabis flower. Fortunately, the country's 40,000 cannabis consumers are once again able to procure their medicine,...
Hopes of medical cannabis in Nebraska being voted on during the November ballot have gone up in smoke, following a decision by the state's Supreme Court.
Judges ruled to drop the forthcoming vote...
In mid-September, Gov. Michelle Lujan Grisham requested that the federal government contribute more financial assistance to help New Mexico recover from a coronavirus-related revenue glut.
Something...
A coalition of county officials are recommending New York cannabis legalization as a means of reversing the economic glut that has occurred as a result of the coronavirus (COVID-19) outbreak.
Adult-use...
In March 2019, a $300 million joint business partnership was struck between Amyris and LAVVAN for the development of synthetic cannabinoids. The research, collaboration and license agreement has taken...
Newly-hired Wall Street employees no longer need to undergo cannabis drug testing, based on a recent report by Business Insider. The report, which saw reporters consult with officials at seven major banks...
